Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTPRC | P08575 | 2/20 | 0.31 |
| ▸ | CTSL | P07711 | 1/20 | 0.31 |
| ▸ | CTSS | P25774 | 1/20 | 0.31 |
| ▸ | PTPN13 | Q12923 | 1/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | ATM | Q13315 | 1/20 | 0.31 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22929888 | 0.89 | MAPT (0.38) | PTPRCCTSLCTSSPTPN13KDM4E | |
| SCHEMBL22930027 | 0.87 | KDM4E (0.41) | PTPRCCTSLCTSSPTPN13KDM4E | |
| SCHEMBL22929960 | 0.85 | TGFBR1 (0.35) | PTPRCCTSLCTSSPTPN13KDM4E | |
| SCHEMBL22929959 | 0.83 | PIM1 (0.32) | PTPRCCTSLCTSSPTPN13KDM4E | |
| SCHEMBL22929904 | 0.83 | KDM4E (0.42) | PTPRCCTSLCTSSPTPN13KDM4E | |
| SCHEMBL22929954 | 0.83 | — | — | |
| SCHEMBL22929955 | 0.82 | ATM (0.35) | PTPRCKDM4EATML3MBTL1 | |
| SCHEMBL22930035 | 0.81 | CYP11B2 (0.32) | PTPRCCTSLCTSSPTPN13KDM4E | |
| SCHEMBL22929920 | 0.80 | KDM4E (0.39) | PTPRCCTSLCTSSPTPN13KDM4E | |
| SCHEMBL17297257 | 0.80 | ATM (0.42) | KDM4EATML3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10910577-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2021-02-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10910577-B2 | Organic electroluminescent materials and devices | CACNA2D2, ORC3, ANO2 | PTPRC 251/4885CTSL 4185/4885CTSS 3843/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.